QNCX
Quince Therapeutics Inc.
Company Overview
| Mkt Cap | $85.94M | Price | $1.57 |
| Volume | 159.72K | Change | -3.68% |
| P/E Ratio | -1.5 | Open | $1.56 |
| Revenue | -- | Prev Close | $1.63 |
| Net Income | $-56.8M | 52W Range | $0.72 - $2.45 |
| Div Yield | N/A | Target | $7.40 |
| Overall | 34 | Value | 40 |
| Quality | 26 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyQuince Therapeutics Inc. (QNCX) is a leading diversified company in the business industry, currently trading at $1.57 with a market capitalization of $85.94 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 26.
Today's trading session shows QNCX with a volume of 160K shares. The stock opened down 4.29% from yesterday's close of $1.63. Current analyst estimates project earnings of $-1.07 per share for this year, with next year targeting $-0.66.
QNCX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for QNCX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 371.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 4, 2025 at 09:41 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | QNCX | $1.57 | -3.7% | 159.72K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Quince Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW